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Abstract 
Aim: The aim of the study was to evaluate the ability of in-vitro planktonic and immobilised 
cell models for determining the antimicrobial efficacy of common antimicrobial wound 
dressings.  
Methods and Results: Five strains of A.baumannii, P.aeruginosa and S. aureus (MRSA) 
were tested against four antimicrobial wound dressings containing silver, honey or PHMB, 
using both a planktonic and immobilised cell model. Across all species and models used, 
the NSCD demonstrated the best antimicrobial activity being as good if not better than all 
the other dressings. The planktonic cell model was less effective at differentiating the 
dressings on antimicrobial performance as the immobilised cell model indicating that a 
diffusion barrier had a significant impact on the performance of some dressings. In the 
presence of the diffusion barrier antimicrobial impact of the Honey and PHMB dressings 
was significantly reduced particularly in the case of A. baumannii. Activity was at least an 
order of magnitude lower in the immobilised cell model vs. the planktonic cell model.  
Conclusions: The use of a planktonic cell model within standard tests may overestimate 
the efficacy of honey and PHMB. The use of an immobilised cell model provides a more 
demanding test for antimicrobial dressings allowing dressing to dressing and   pathogen to 
pathogen differences to be more clearly quantified.  
Significance and Impact of study: The introduction of planktonic and immobilised cell 
models as part of testing regimens for wound dressings will provide a more thorough 
understanding of their antimicrobial and antibiofilm properties.  
Key words: Antimicrobial, Dressings, Biofilm, Planktonic, Wound. 
Introduction: 
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Chronic wounds such as leg and pressure ulcers are commonly seen in primary care 
settings and are often infected or heavily colonised with pathogenic bacteria. Healing of 
these wounds depends on the interplay between the patient’s defence mechanisms and 
the pathogenic organisms present in the wound environment (Stephen-Haynes 2004). 
Within a wound environment, microorganisms may exist in various states i.e. planktonic 
(free floating phenotypic state), or as part of a biofilm (attached phenotypic state) (Thomas 
et al. 2011). A biofilm is defined as a highly organized community of microorganisms 
attached to each other, or to biotic (living) or non-biotic surfaces enclosed in a polymeric 
matrix composed of complex polysaccharides, proteins, nucleic acids and glycoproteins 
(Donlan and Costerton 2002). Biofilms provide a protective environment that allows 
microorganisms to survive harsh environmental conditions such the presence of biocides 
and antibiotics (Donlan and Costerton 2002). Pseudomonas aeruginosa and methicillin 
resistant Staphylococcus aureus (MRSA) are common biofilm forming pathogenic 
organisms that have been observed within the clinical setting (Barrett et al. 1968; Lindsay 
and Von Holy 2006). Acinetobacter baumannii is an emerging biofilm forming pathogen, 
which has become a common source of infection within areas of conflict (Turton et al. 
2006; Sebeny et al. 2008; O'Shea 2012).  
Effective wound management is a multifaceted process that requires the control of 
excessive wound exudate, the elimination of excessive odours, the debridement of 
necrosis, the management of the microbial load and the promotion of tissue regeneration 
(Thomas et al. 2011). In response to these challenges, wound dressings have evolved 
from simple natural materials that covered and concealed the wound, through the use of 
materials that facilitate moisture management, to more modern dressings that attempt to 
actively manage the microbial load and encourage healing (Ovington 2007). 
Advancements in the scientific understanding of wound infections have allowed the 
development of a wide variety of dressings with increased antimicrobial efficacy 
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(Abdelrahman and Newton 2011). However, the formation and presence of biofilms within 
wounds represents a significant challenge to wound management, due to the inherent 
increase in resistance to both antibiotics and chemical treatments associated with biofilm 
formation. 
There are a large range of antimicrobial wound dressings available with varying claims of 
antimicrobial efficacy. Due to the intimate nature of the interface between a wound and the 
dressing, careful selection of antimicrobial additives is of paramount importance. Silver 
and polyhexamethylene biguanide (PHMB) are now established in the market as 
antimicrobial chemical components of wound dressings (Fong and Wood 2006; Castellano 
et al. 2007; Eberlein et al. 2012); alongside these chemical agents honey is also available 
as a natural antimicrobial agent (Stephen-Haynes 2004; Mullai and Menon 2007; 
Bradshaw 2011). Silver has been used medically for thousands of years (Thomas et al. 
2011); within wound care it is generally used in a nanocrystalline or ionic form. Silver is 
thought to act through the inhibition of cellular transport and respiration mechanisms or the 
disruption of transcriptional processes through denaturing of nucleic acids (Fong and 
Wood 2006; Asavavisithchai et al. 2010). In contrast, PHMB is a synthetic polymer mixture 
which is reported to affect cell membrane integrity resulting ultimately in the lysis of cells 
(Moore and Gray 2007). A range of honeys with antimicrobial properties is available 
including Manuka (New Zealand), Heather (UK) and Khandikraft (India) and these can 
vary substantially in their antimicrobial activity. The antimicrobial nature of honey is related 
to a number of properties including its pH, high osmolarity and the presence of hydrogen 
peroxide and phytochemicals (Stephen-Haynes 2004). However, it is thought that the 
principal mode of action is through the presence of hydrogen peroxides and 
phytochemicals, the mechanisms of which are poorly understood (French et al. 2005; 
Mullai and Menon 2007; Olaitan et al. 2007).  
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Previous procedures for the evaluation of the antimicrobial activity of wound dressings 
have varied significantly in terms of media used, inoculum and sample size (Tkachenko 
and Karas 2012), making the direct comparison of the antimicrobial efficacy of dressings 
difficult (Chopra 2007). Recent developments have seen the publishing of a draft standard 
test method for assessing the antimicrobial activity of wound dressings (BSI 2014). The 
draft standard currently allows the selection of either a direct contact (Gallant‐Behm et al. 
2005), shaking (Parsons et al. 2005) or a two compartment method (Agren and 
Mirastschijski 2004) employing planktonic cells of Pseudomonas aeruginosa, 
Staphylococcus aureus and Candida albicans prepared in a simulated wound fluid 
containing foetal bovine serum, with no guidance as to which approach is preferred.  
However, for the effective eradication of microorganisms within a biofilm, higher 
concentrations of antimicrobial agent are often required when compared with their 
planktonic or free floating non-biofilm counterparts (Thomas et al. 2011). Often the 
antimicrobial concentrations required for the removal can be 100-fold greater than that 
required for removal of micro-organisms in the planktonic state (Rasmussen and Givskov 
2006). Consequently, a model system able to simulate the diffusion barrier created by an 
established wound biofilm would complement the existing testing approaches based on 
planktonic cells (BSI 2014); such a system would provide a model for the treatment of 
chronically infected wounds where biofilms are more prevalent. The aim of the following 
study was to determine if the presence of a diffusion barrier has a significant impact on the 
performance of antimicrobial wound dressings when compared to an approach employing 
planktonic cells.  The data generated from this study may aid the development of the 
current draft test method (BS EN16756:2014) in order to determine whether strain 
selection or the incorporation of a diffusion barrier are worthy of consideration for the final 
version of the standard.  
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Materials and methods 
Bacterial strains 
Five strains of Pseudomonas aeruginosa, methicillin resistant Staphylococcus aureus 
(MRSA) and Acinetobacter baumannii were selected as candidate organisms for testing. 
Of the five strains selected from each group, a mix of type- and clinical/community- 
acquired strains were selected and are summarised in table 1. 
Dressings 
Four commercially available dressings were selected for evaluation: a Manuka honey 
based dressing (Actilite, Advancis medical, UK), a polyhexamethylene biguanide (PHMB) 
based dressing (Suprasorb, Lohmann and Rauscher, Germany), a nanocrystalline silver 
coated dressing (NSCD; Acticoat absorbent, Smith & Nephew Medical ltd, UK) and an 
ionic silver coated dressing (ISCD; Aquacel Ag, Convatec, UK). 
Planktonic cell model 
A bacterial suspension of 1.0 - 1.5x108 CFU ml-1 was prepared in maximum recovery 
diluent (MRD; Lab M) as per previous methods (BSI 2009; White et al. 2012). From this 
bacterial stock, a 1.0 - 1.5x105 CFU ml-1 suspension was prepared in simulated wound 
fluid (SWF; 50% v/v foetal calf serum (Sigma, UK) in MRD) and used as an inoculum for 
subsequent testing. A 16 cm2 portion of dressing was placed on a sterile plastic sheet in 
the base of a sterile Petri dish, 400 µl of inoculum was added to the surface of the dressing 
before being covered with a second layer of sterile plastic. The inoculated dressings were 
then incubated for 24 hours at 37°C and 90 % humidity. Following incubation the top and 
bottom plastic layers, alongside the dressing were each transferred to a sterile stomacher 
bag containing 10 ml of a validated neutraliser, sealed, and stomached for 20 minutes. A 
range of dilutions of the neutralisation mixture were then prepared in MRD and plated out 
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onto tryptone soya agar (TSA; LabM, UK). In addition, the stomached dressing and plastic 
layers were aseptically removed and transferred to Petri dishes and immersed with molten 
TSA, prior to incubation at 37ºC for 24-48 hours. Suitable controls were carried out in line 
with previously described testing methods (BSI 2007); here the active dressing was 
replaced with a piece of sterile plastic and processed as described above. The impact of 
the dressings was determined as a log reduction factor (per cm2) calculated by 
comparison with the number of bacteria recovered from controls (BSI 2007).  
Immobilised cell model 
In order to determine the efficacy of dressings in the presence of a diffusion barrier, an in 
vitro immobilised cell model mimicking the presence of a biofilm in a chronic wound was 
selected based on previous methods (Brackman et al. 2011). Matrices of polymerized rat-
tail collagen type I (BD Biosciences UK) were prepared in 15 ml tubes following the 
manufacturer’s protocol for eukaryotic cell culturing. To prepare 10 ml of collagen matrix 
solution (3.8 g l-1), 1ml of phosphate buffer saline (PBS) was mixed with 0.019 ml of NaOH 
(1 mol l-1) and 0.711 ml of inoculum (prepared in SWF) and kept on ice. Finally 8.27 ml of 
collagen from cold collagen stock (4 g l-1) was added and, after mixing, 1ml of collagen 
matrix was added in each well of polystyrene microtiter plate (Nunclon surface 24 well 
plates, Fisher Scientific, UK). Following polymerisation for 1 hour at 37ºC, dressing was 
added to the top of the matrix and incubated for 24 hours at 37°C and 90% humidity. In 
order to enumerate the surviving bacteria, dressings were removed following incubation 
and 1ml of collagenase solution added to the wells (1 g l-1 in PBS from Clostridium 
histolyticum (Sigma Aldrich, UK)), the suspension was then completely mixed and 
incubated at 37°C until the collagen was completely digested (60-80 minutes). The 
contents of the well were then added to 10 ml of validated neutraliser and plated out onto 
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TSA alongside the dressings, controls were carried out in the same manner and the 
surviving fraction of bacteria calculated as per the planktonic cell model.  
Statistical analysis 
All statistical analysis was carried out on IBM SPSS Statistics 20 for Windows.  One-way 
between groups ANOVAs were conducted to evaluate the effect of dressing type 
(independent variable) on number of bacteria (dependent variable) for each model, with 
the Games-Howell post hoc test used to identify significant differences between variables.  
Because the data were not normally distributed and, in most cases, the assumption of 
homogeneity of variance was violated, the more robust Welch F-ratio is reported.  The 
difference in Log reduction between the two models was evaluated using independent t-
tests. 
Results  
The mean Log number of organisms per cm2 recovered from control pieces can be seen in 
supplementary table S1. In the case of both Acinetobacter and Pseudomonas species, 
there was no obvious difference between the yield of microorganisms observed within 
either the planktonic or immobilised cell model. Within the MRSA isolates, a greater Log 
recovery of microorganisms was observed using the immobilised cell model rather than 
the planktonic model, suggesting that the growth of the selected MRSA strains was 
enhanced through the immobilisation within collagen. 
The mean antimicrobial activity demonstrated by each wound dressing against each 
species, for the planktonic [A. baumannii F(3, 58.33) = 792.54, p <0.001; P. aeruginosa 
F(3,75.10) = 6.54, p = 0.001; MRSA F(3,38.35) = 8.35, p <0.001] and immobilised cell 
models [A. baumannii F(3, 55.70) = 3244.80, p < 0.001; P. aeruginosa F(3,91.31) = 41.40, 
p < 0.001; MRSA F(3, 57.25) = 37.08, p <0.001], can be seen in table 2. In both the 
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planktonic and the immobilised cell model, there were significant differences by dressing 
within each species (see Figures 1a and 1b). A comparison of the two models can be seen 
in Figure 2; the planktonic model demonstrated a significantly greater Log reduction in 
viable counts compared with the immobilised cell model, with the exception of the ISCD 
dressing, which was more effective in the immobilised cell model against A baumannii. 
There was considerable difference between individual strains in the Log reductions 
observed (see Figures 3, 4 & 5). Within both models, A. baumannii strain 822 was less 
susceptible to the silver dressings than the other isolates (Figure 3). The NSCD dressing 
resulted in a total kill in both models for the other strains of A. baumannii; the significant 
difference in Log reduction observed in Figure 2 appears to be due to the greater Log 
reduction of strain 882 in the planktonic model. The honey dressing was much less 
effective against strain 882 compared with the other strains of A. baumannii in the 
planktonic model, but was more susceptible in the immobilised cell model. 
A total kill was observed with the P. aeruginosa Type strain in the immobilised cell model 
for the PHMB, ISCD, and NSCD dressings, and in the planktonic model for the NSCD 
dressing (Figure 4). The dressings were considerably less effective against the other 
strains for P. aeruginosa when tested using the planktonic model, although the difference 
in effectiveness was less for the NSCD dressing compared with the other dressings. 
Within the MRSA testing, greater Log reductions were seen across the planktonic model 
compared with the immobilised cell model for most strains of MRSA, with the notable 
exceptions of strain 6538 and 7F/C7 when treated with the silver coated ISCD dressing 
(Figure 5).  
Discussion 
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A wide variety of test methods have been employed to evaluate antimicrobial wound 
dressings, from simple zone of inhibition testing, to more complex broth based methods 
(Chopra 2007; Tkachenko and Karas 2012). In order to standardise the methods by which 
these dressings are compared, a draft standard for testing has been devised using broth 
based methods against planktonic cells (BSI 2014). In this study we have assessed a 
range of antimicrobial dressings against both Gram positive and negative pathogens using 
both a planktonic model similar to those suggested in the current draft standard and an 
immobilised cell model chosen to mimic the diffusion barrier generated by the presence of 
a biofilm. In particular, the immobilised cell model provides a consistent wound 
environment with which to determine the anti-biofilm forming properties of wound 
dressings which greater reflects the in vivo than the planktonic model. The method is 
reproducible and allows for simple, cost effective enumeration through plating methods in 
comparison to other published strategies using fluorescence (Brackman et al. 2013). 
The immobilised cell model presented here is also capable of yielding results within 48 
hours. Previous studies have required up to 48 hours to prepare a suitable biofilm for study 
against antimicrobials (Thorn et al. 2009; Hill et al. 2010; Kucera et al. 2014), as such the 
immobilised cell model is provides an alternative that may improve timescales in which 
candidate dressings are tested at a clinical level (Durante 2012).    
Within the planktonic model, the greatest Log reductions in viable cell counts was 
observed with the nano-crystalline silver dressings, with total kills observed with four of the 
A. baumannii strains, one of the P. aeruginosa strains and two of the MRSA strains within 
24 hours. In a similar fashion, previous authors have also found that a complete kill was 
observed within 24 hours when testing against NSCD and ISCD against Gram positive and 
negative isolates using a similar planktonic cell testing method (Ip et al. 2006; Tkachenko 
and Karas 2012). Within our planktonic model, no complete kills were observed with ISCD; 
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however, when tested with the immobilised cell model, ISCD produced comparable results 
to NSCD against A. baumannii and MRSA isolates. The efficacy of the honey and PHMB 
dressings were most impacted by the use of the immobilised cell model across all three 
isolates, which agreed with previous work suggesting that honey was more effective 
against planktonic isolates over those within biofilms (Alandejani et al. 2009; Merckoll et al. 
2009). In particular, P. aeruginosa and A. baumannii were less susceptible to honey and 
MRSA less susceptible to PHMB, within the immobilised cell model. The reduced 
susceptibility of P. aeruginosa to Honey when compared to S. aureus has recently been 
reported (Lu et al. 2013). This reduced susceptibility may be due to the catalase activity of 
these species reducing the impact of the hydrogen peroxide generated by the Honey 
dressing. The impact of catalase activity on the biocidal impacts of hydrogen peroxide 
have been specifically reported for A. baumanii (Herruzo et al. 2014). Previous work has 
suggested that PHMB is effective against MRSA within a wound environment when 
applied directly (Wild et al. 2012), and as such this result may be a reflection of the 
diffusion of PHMB from the dressing into the biofilm rather than of the activity of the 
chemical itself. Clinical trials investigating the usage of PHMB dressings also suggest that 
beneficial effects against biofilms required prolonged use of up to 28 days to achieve 
results against biofilms of critically colonised patients (Fong and Wood 2006).  
Strain selection for any potential testing method was also investigated. In both the 
planktonic and immobilised cell model, variation was seen with isolates of the same 
species, suggesting that strains selection may be important when finalising a standard test 
method. Of particular note, within the immobilised cell model (Figures 3, 4 & 5) Type 
strains were more susceptible to the active ingredients than clinical isolates. This result 
agrees with the previous data using an in vitro model employing zone of inhibition tests, 
which found no significant differences between the dressings tested, but found that 
differences occurred between strains (Du Toit and Page 2009). These observed 
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differences between clinical and type strains will contribute to patient to patient variations 
in the efficacy of antimicrobial dressings and emphasise the caution required when 
translating in-vitro data into clinical settings.  
In summary, our findings indicate that an immobilised cell model provides a more rigorous 
testing strategy for antimicrobial wound dressings than the planktonic models reported in 
the literature and proposed in the draft standard (BSI 2014). The immobilised cell model 
evaluated here was more effective at differentiating between antimicrobial dressings and 
highlighting those most susceptible to the presence of a diffusion barrier (PHMB and 
Honey), which may in turn indicate that they are less suitable for the prevention of chronic 
biofilm formation. In addition, the variation observed between strains suggests that clinical 
identification of strains present within a wound may still play an important role in wound 
management. 
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Species Name Isolate Source 
 
 
Pseudomonas 
aeruginosa 
10421 Type NCIMB 
 
 
I Clinical 
Isolated from a wound 
dressing. 
 
 
II Clinical 
 
 
III Clinical 
 
 
IV Clinical 
 
 
Acinetobacter 
baumannii 
19606 Type ATCC 
 
 
OXA -
24 
Clone I 
Clinical 
Provided by LHCAI, HPA 
Colindale, London.  
 
OXA -
24 
Clone II 
Clinical 
 
 
Hospital Clinical Provided by Dr M. Wren, UCLH, London.  
 
 
CIP 
106882 
Culture 
Collection 
Pasteur Institute,              
Paris, France. 
 
 
Methicillin resistant 
Staphylococcus aureus 
6538 Culture Collection ATCC 
 
 
43300 Culture Collection ATCC 
 
 
13142 Culture Collection NCTC 
 
 
7F/C7 Community 
acquired 
Previous Study, White et al 
2012. 
 
 
9B/F6 Community 
acquired 
Previous Study, White et al 
2012. 
 Table 1: Bacterial strains used in this study. 
 
 Dressing  
 NSCD ISCD Honey PHMB  
Mean SD Mean SD Mean SD Mean SD P 
Planktonic cell model          
A. baumannii 9.09 1.01 6.53 0.54 7.69 2.51 3.95 0.73 <0.001 
P. aeruginosa 7.70 0.65 6.93 1.05 7.10 1.10 6.42 2.05 0.001 
MRSA 6.97 0.41 5.55 1.86 6.58 0.48 6.12 0.79 <0.001 
Immobilised cell model          
A. baumannii 8.26 0.87 8.18 1.03 3.10 1.09 2.93 0.35 <0.001 
P. aeruginosa 6.90 0.74 5.95 1.33 3.55 1.24 5.23 1.79 <0.001 
MRSA 6.20 1.33 6.22 1.30 5.09 0.39 3.71 0.44 <0.001 
 
Table 2. Mean (SD) difference between control and test, where a larger number indicates 
more bacteria killed  
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Figure 1 Mean antimicrobial activity of NSCD (     ), ISCD (     ) Honey (     ) and PHMB (     ) 
wound dressings, against five strains of A. baumannii, P. aeruginosa and MRSA isolates 
using the planktonic model (A) and the immobilised cell model (B). One-way between groups 
ANOVAs with Games-Howell post hoc tests were used to identify significant differences in 
the impact of dressing within species; different letters indicate significant differences between 
dressings within species.  
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Figure 2: Collective comparison of planktonic (white bars) and immobilised cell models (grey 
bars) of each dressing tested for each species tested, error bars represent the standard 
deviation (n= 25); The difference in Log reduction between the two models was evaluated 
using independent t-tests, * p<0.05, ** p < 0.01, *** p < 0.001.  
 
Figure 3. Comparison of Log reduction between the planktonic (white bars) and immobilised 
cell (grey bars) models by dressing and bacterial strain for A. baumannii. 
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Figure 4. Comparison of Log reduction between the planktonic (white bars) and immobilised 
cell (grey bars) models by dressing and bacterial strain for P. aeruginosa. 
 
Figure 5. Comparison of Log reduction between the planktonic (white bars) and immobilised 
cell (grey bars) models by dressing and bacterial strain for MRSA. 
